02 August 2010
Main tasks in project
Two departments of the RIVM will be involved in the project. The Laboratory for Health Protection Research (GBO) is dedicated to toxicological research in order to provide policy support to the government. GBO investigates, how substances or biological products can either improve or damage health. The Centre for Substances and Integrated Risk Assessment (SIR) evaluates the health risks of various types of substances including modelling of internal exposure and biokinetics. RIVM is WP leader for the WP on toxicokinetics investigating the tissue distribution and kinetics of the ENM in the body. In addition, RIVM contributes to WP5 and WP6 dealing with in vitro and in vivo determination of possible genotoxicity of the ENMs.
RIVM and Nanotechnology
RIVM is a well known government centre in human and environmental hazard and risk assessment. Within the RIVM staff members from all centres/laboratories working on nanotechnology have joined forces in an institute-wide working group. The safety of nanoscience and nanotechnology products is one of the subjects of research as an emerging technology with potential risks for health and environment. Staff involved in the NANOGENOTOX Joint Action Plan has extensive experience in nano(eco)toxicology and modelling research. RIVM participates amongst others in NanoImpactNet, NanoInteract, EU-Observatory, Framing-Nano, ENPRA, CADASTER (with project coordination by RIVM). By the order of the NL Ministry of Housing, Spatial Planning and the Environment, RIVM is represented in the OECD Working Party Manufactured Nanomaterials (WPMN). RIVM also provides scientific input for the Dutch Competent Authorities on these issues. RIVM is assigned as the coordination agency for all exposure, effect and risk assessment issues related to manufacturing, processing, and applying ENMs in the Netherlands. RIVM acts on behalf of 5 Dutch Ministries in this respect. In addition to dealing with regulation of ENMs in both Europe and the Netherlands, RIVM performs scientific research in support of future risk assessment of ENMs.Last Updated on Wednesday, 22 September 2010 10:07